Nexgel, INC Form 4 insider transactions

Adam R. Levy, Chief Executive Officer and a Director of Nexgel, Inc., received 160,000 shares of common stock on July 23, 2026.

NEXGEL, Inc. CEO Adam R. Levy reported the sale of 3,000 shares of common stock in an open market transaction.

NEXGEL, Inc. CEO Adam R. Levy reported the sale of 6,000 shares of common stock in open market transactions.

NEXGEL, Inc. CEO Adam R. Levy reported the sale of 2,000 shares of common stock in an open market transaction.

NEXGEL, Inc. CEO Adam R. Levy reported the sale of 13,000 shares of common stock in open market transactions.

Director Scott Robert Henry acquired a $25,000 convertible promissory note and associated warrants in NEXGEL, Inc.

Director Brian Kieser acquired a $1 million convertible promissory note and associated warrants in NEXGEL, Inc.

NEXGEL, Inc. CEO Adam Levy acquired a $60,000 convertible promissory note and warrants for 50,000 shares of common stock.

NEXGEL's CEO, Adam R. Levy, reported the sale of 10,000 shares of common stock in two separate transactions for tax planning purposes.

NEXGEL CEO Adam R. Levy sold 4,000 shares of common stock for tax planning purposes under a Rule 10b5-1 trading plan.

NEXGEL, INC. Director Scott Robert Henry sold a total of 8,000 shares of common stock in early October 2025 through a pre-arranged Rule 10b5-1 trading plan.

NEXGEL CEO Adam R. Levy sold 4,000 shares of common stock in early October 2025 through a pre-arranged 10b5-1 trading plan for tax planning purposes.

NEXGEL Director Scott Robert Henry sold 7,697 shares of common stock for a weighted average price of $2.3579 per share, executed under a pre-arranged Rule 10b5-1 trading plan.

NEXGEL CEO Adam R. Levy sold 4,000 shares of common stock at a weighted average price of $2.4741 for tax planning purposes.

NEXGEL, Inc. Director Steven Mark Glassman was granted 30,000 stock options and 5,000 restricted stock units (RSUs) on June 25, 2025, as compensation for his service on the Board of Directors.

NEXGEL, Inc. Director and Audit Committee Chairperson Scott Robert Henry was granted 30,000 stock options and 5,000 restricted stock units (RSUs) as part of his compensation for services.

NEXGEL, Inc. Director Jerome B. Zeldis has been granted 30,000 stock options at an exercise price of $2.32 per share, vesting monthly over 12 months.

NEXGEL, Inc. Director John Nachum Stein was granted 30,000 stock options with an exercise price of $2.32, vesting monthly over 12 months starting July 31, 2025.

NEXGEL, Inc. Director Scott Robert Henry sold 3,000 shares of common stock on June 13, 2025, through a Rule 10b5-1 trading plan.

NEXGEL, Inc. CEO and Director Adam R. Levy reported the sale of 4,000 shares of common stock in two separate open market transactions for tax planning purposes.

NEXGEL, Inc. CEO Adam R. Levy reported the sale of 2,000 shares of common stock over two days in early June 2025, citing tax planning as the reason.

NEXGEL, Inc. CEO Adam R. Levy filed a Form 4 disclosing the sale of 1,000 shares of common stock for tax planning purposes, retaining a significant beneficial ownership.

NEXGEL's CEO, Adam R. Levy, sold 1,000 shares of common stock at $2.575 per share on May 16, 2025, for tax planning purposes.

Director Scott Robert Henry of NEXGEL, INC. sold 3,000 shares of common stock at an average price of $2.6873 per share on May 12, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Director Scott Robert Henry sold 3,000 shares of NEXGEL, INC. common stock at an average price of $2.6083 per share on April 10, 2025, under a pre-arranged Rule 10b5-1 trading plan.

NEXGEL's CEO, Adam R. Levy, sold 4,000 shares of common stock on April 1, 2025, at an average price of $3.0096 per share, according to a Form 4 filing.

Director Scott Robert Henry of NEXGEL, INC. executed a sale of 3,000 common stock shares on March 10, 2025, under a pre-arranged Rule 10b5-1 trading plan.

NEXGEL's CEO, Adam R. Levy, sold 4,000 shares of common stock on March 3, 2025, at an average price of $3.1597 per share, as part of a pre-arranged Rule 10b5-1 trading plan for tax planning purposes.

Director Steven Mark Glassman reports acquiring 2,500 shares of NEXGEL, INC. common stock as compensation for services.

Director Scott Robert Henry of NEXGEL, INC. reports selling 3,000 shares and acquiring 2,500 shares of common stock.